The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Showing 1-4 of 4 articles
Economic evaluation of fractional flow reserve-guided versus angiography-guided multivessel revascularisation in ST-segment elevation myocardial infarction patients in the FLOWER-MI randomised trial
Le Bras A,
Puymirat E,
Rabetrano H,
Cayla G,
Simon T,
Steg G,
Montalescot G,
Varenne O,
Bonello L,
Coste P,
Delarche N,
Georges J,
Chassaing S,
Letocart V,
Chatellier G,
Danchin N,
Durand-Zaleski I
June 24, 2022 | 10.4244/EIJ-D-21-00867
The people left behind: refining priorities for health care during and after the pandemic
July 17, 2020 | 10.4244/EIJY20M06-01
Polymer-free drug-coated coronary stents are cost-effective in patients at high bleeding risk: economic evaluation of the LEADERS FREE trial
Filipovic-Pierucci A,
Durand-Zaleski I,
Butel T,
Greene S,
Hovasse T,
Iñiguez A,
Nazzaro M,
Oldroyd K,
Talwar S,
Richardt G,
Windhovel U,
Urban P,
Morice M
February 20, 2018 | 10.4244/EIJ-D-17-00286
The SYNERGY II Everolimus elutiNg stent In patients Older than 75 years undergoing coronary Revascularisation associated with a short dual antiplatelet therapy (SENIOR) trial: rationale and design of a large-scale randomised multicentre study
Varenne O,
Cuisset T,
Chaib A,
Morice M,
Sabaté M,
Koh T-H,
Durand-Zaleski I,
Hanon O,
Bogaerts K,
Sinnaeve P
January 20, 2017 | 10.4244/EIJY15M12_02